Publicaciones en las que colabora con P. Coto-Segura (79)

2024

  1. Influence of the HLA-Cw6 Allele and IFIH1/MDA5 Gene Variants on the Cardiometabolic Risk Profile of Patients with Psoriatic Disease

    Journal of Clinical Medicine, Vol. 13, Núm. 3

2023

  1. The IFIH1/MDA5 rs1990760 Gene Variant (946Thr) Differentiates Early- vs. Late-Onset Skin Disease and Increases the Risk of Arthritis in a Spanish Cohort of Psoriasis

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

2022

  1. Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA-C ∗ 06 Status

    BioMed Research International, Vol. 2022

  2. Vesiculobullous skin reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature

    Clinical and Experimental Dermatology

2021

  1. Dermografismo blanco como manifestación cutánea atípica de la COVID-19: (Pages. e55-e56)

    Semergen: revista española de medicina de familia, Núm. 7, pp. 506-506

  2. Genetic variants of the NF-κB pathway: Unraveling the genetic architecture of psoriatic disease

    International Journal of Molecular Sciences, Vol. 22, Núm. 23

  3. White dermographism as an atypical cutaneous manifestation of COVID-19

    Semergen, Vol. 47, Núm. 7, pp. e55-e56

2020

  1. Dermatologists’ Role in the Early Diagnosis of Psoriatic Arthritis: Expert Recommendations

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 10, pp. 835-846

  2. Linguistic and Cultural Adaptation to Spanish of the Screening Tool Psoriatic Arthritis UnclutteRed Screening Evaluation (PURE4)

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 8, pp. 655-664

2019

  1. NFKBIZ and CW6 in Adalimumab Response Among Psoriasis Patients: Genetic Association and Alternative Transcript Analysis

    Molecular Diagnosis and Therapy, Vol. 23, Núm. 5, pp. 627-633

  2. Gene Variant in the NF- κ B Pathway Inhibitor NFKBIA Distinguishes Patients with Psoriatic Arthritis within the Spectrum of Psoriatic Disease

    BioMed Research International, Vol. 2019

  3. Gut microbiota dysbiosis in a cohort of patients with psoriasis

    British Journal of Dermatology, Vol. 181, Núm. 6, pp. 1287-1295

2018

  1. Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and their association with type 2 diabetes and impaired renal function

    Human Immunology, Vol. 79, Núm. 6, pp. 494-498

  2. Genetic Variation in the H19-IGF2 Cluster Might Confer Risk of Developing Impaired Renal Function

    DNA and Cell Biology, Vol. 37, Núm. 7, pp. 617-625

  3. High rates of tuberculin skin test positivity due to methotrexate therapy: False positive results?

    Seminars in Arthritis and Rheumatism, Vol. 48, Núm. 3, pp. 538-546

  4. IL17RA gene variants and anti-TNF response among psoriasis patients

    Pharmacogenomics Journal, Vol. 18, Núm. 1, pp. 76-80

  5. Ustekinumab in psoriatic arthritis: need for studies from real-world evidence

    Expert Opinion on Biological Therapy

2017

  1. NFKBIZ in Psoriasis: Assessing the association with gene polymorphisms and report of a new transcript variant

    Human Immunology, Vol. 78, Núm. 5-6, pp. 435-440

  2. Sentinel lymph node biopsy plus wide local excision vs. wide location excision alone for primary cutaneous melanoma: a systematic review and meta-analysis

    Journal of the European Academy of Dermatology and Venereology, Vol. 31, Núm. 2, pp. 241-246

2016

  1. A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing Spondylitis

    PLoS ONE, Vol. 11, Núm. 7